Navigation Links
AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
Date:8/5/2013

REDWOOD CITY, Calif., Aug. 5, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO, will present a corporate overview at the Canaccord Genuity 33rd Annual Growth Conference at the Intercontinental Boston, Boston, MA.  The presentation is scheduled for Thursday, August 15, 2013 at 2:30 p.m. ET/11:30 a.m. PT.

The presentation will be webcast live and can be accessed through the Investors page at www.acelrx.com.  For those not available to listen to the live broadcast, a replay of the presentations will be archived for 90 days and available through the Investors page on www.acelrx.com.

About AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain.  AcelRx's lead product candidate, Zalviso, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive IV route of delivery and the complexity of infusion pumps.  AcelRx has announced positive results from each of the three Phase 3 clinical trials for Zalviso and AcelRx anticipates submitting a New Drug Application with the FDA in the third quarter of 2013. AcelRx also announced positive top-line results for a Phase 2 trial for ARX-04, a sufentanil formulation for the treatment of moderat
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results
2. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
3. AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
4. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
5. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
6. AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
7. AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
8. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
9. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
10. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
11. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... , 6. März 2015  Unfors ... Röntgenstrahlen, feierte auf dem European Congress of ... , Österreich, die 1.000. Installation seines Systems ... Logo - http://photos.prnewswire.com/prnh/20150304/179432LOGO ... der in Echtzeit Informationen über die Dosis ...
(Date:3/6/2015)... 6, 2015  AbbVie (NYSE: ABBV ) ... on Thursday, March 12, 2015. Richard A. Gonzalez ... a question and answer session at 8:30 a.m. Central ... presentation will be accessible through AbbVie,s Investor Relations Web ... the session will be available later that day. ...
(Date:3/6/2015)... , March 6, 2015   Veracyte, Inc. ... demonstrating that diagnostic tests that use increasing numbers of ... reduce the specificity of test results, leading to an ... erroneously diagnosed as cancerous. In addition, these new data ... the malignancies leading to "false negatives." The data were ...
Breaking Medicine Technology:Unfors RaySafe, ein Unternehmen von Fluke Biomedical, feiert 1.000. Installation seines Systems zur Echtzeit-Strahlendosimetrie 2Unfors RaySafe, ein Unternehmen von Fluke Biomedical, feiert 1.000. Installation seines Systems zur Echtzeit-Strahlendosimetrie 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 2Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 4Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 5Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 6
... Inc. (NYSE AMEX: ULU) today announced that it ... ended September 30, 2011 financial results and to provide a ... a.m. Eastern Time. To participate in the conference ... 429-1388 (access code 23823#) five to ten minutes prior to ...
... FRANCISCO, Nov. 11, 2011 Boston Scientific Corporation ... the EVOLVE First Human Use trial demonstrating the ... to the PROMUS Element™ Everolimus-Eluting Stent System in ...  The trial provided 30-day clinical and six-month angiographic ...
Cached Medicine Technology:ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2011 and to Provide a Business Update 2Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 2Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 3Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 4Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 5
(Date:3/6/2015)... March 06, 2015 Johnson & Johnson ... verdict on March 5, 2015 in Superior Court in ... court documents, a jury of 12 awarded Mrs. Perry ... being implanted with an Ethicon TVT Abbrevo plastic sling ... and three women also awarded $5 million in punitive ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Many patients ... despite medical therapy. If you (or someone you know) ... knee osteoarthritis, you may be interested in the ACT-OA ... Orthopedic announced today that he is one of fifteen ... Therapeutics to begin enrolling subjects as part of a ...
(Date:3/6/2015)... 2015 Truly Nolen, the largest family-owned ... the grand opening of their first independently-owned and operated ... to the Fort Mill – Rock Hill, SC area. ... 2015 at their new location. , The ... collective experience in the pest control industry. Locally owned ...
(Date:3/6/2015)... 2015 Yisrayl Hawkins, Pastor and Overseer ... released a new publication explaining how micro-kingdoms keep the ... The article titled “Microorganisms Do Much More Than You ... microorganisms were created and designed to keep all things ... of the functions of these micro-kingdom, but does not ...
(Date:3/6/2015)... FCPX developers have announced a ... , “Pro3rd Hue is a lower 3rd pack with a ... Film Studios. “Blurring the line between professional and armature, Pro3rd ... a set of 30 customizable lower third presets made exclusively ... FCPX users can complement any design with a clean and ...
Breaking Medicine News(10 mins):Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:First Truly Nolen Franchise Opening in North Carolina 2Health News:Yisrayl Hawkins Tells Scientists Exactly What Makes Life Function Properly in New Publication 2Health News:A New Plugin Entitled Pro3rd Hue was Released Today from Pixel Film Studios Exclusively for FCPX 2
... the rate of common, costly and potentially lethal catheter-related ... using cheap//, low-tech, common-sense measures like hand washing, timely ... than the groin to place lines when possible, according ... any more not to do these relatively simple things,” ...
... to investigate the reason why the common parasite Toxoplasma,// ... make many others seriously ill. , ,Toxoplasma is ... cats, but can also be passed on by many ... called toxoplasmosis, which in normal circumstances is not harmful, ...
... a zebrafish loses a chunk of its tail fin, it’ll ... a zebrafish can replace surprisingly complex body parts. A tail ... is a very intricate structure. It is the fish version ... cold-blooded animals re-grow missing tails and other appendages has fascinated ...
... guru Baba Ramdev said here Wednesday that soft drinks //should ... only fruit juice and milk to keep diseases away. ... Science College ground here at a camp, Ramdev said: "Take ... everyday early morning rather than consuming cold drinks., ,"Cold ...
... a modified strain, has led to the death of a ... pre mature babies are undergoing treatment. ,The babies ... after they were found to be carriers of Panton-Valentine Leukocidin ... ,Hospital authorities have confirmed that the baby died due ...
... in New York are having a nice holiday with medical ... is called Clown Care and believes in the saying “laughter ... New York-Presbyterian Hospital runs this program. It is a residential ... introduced by Michael Christensen, co-founder of Big Apple Circus. ...
Cached Medicine News:Health News:Safer ICU’s: Cheap, Simple, “Low-Tech” Steps W 2Health News:Regrowth of Zebrafish's Tail Fin may Offer Clues for Treating Human Injuries 2Health News:Regrowth of Zebrafish's Tail Fin may Offer Clues for Treating Human Injuries 3
For the critical care environment, telemetry, emergency room and other monitoring areas....
The CIC Pro Clinical Information Center brings together vital patient information from multiple monitoring devices....
... Central Station is a solution for ... for vital signs monitoring. Waveform and ... time, with simultaneous display of up ... and tabular trends are stored automatically. ...
... List Editor) Multi-Channel Infusion System brings a ... instrument combines three independent infusion channels with ... unparalleled small size. Now with Advanced Dose ... simplifies the delivery of complex drug regimens. ...
Medicine Products: